Affinity DataIC50: <0.100nMAssay Description:Inhibition of BRAFMore data for this Ligand-Target Pair
Affinity DataIC50: <0.100nMAssay Description:Inhibition of BRAFMore data for this Ligand-Target Pair
Affinity DataIC50: <0.320nMAssay Description:Inhibition of BRAFMore data for this Ligand-Target Pair
Affinity DataIC50: <0.320nMAssay Description:Inhibition of BRAFMore data for this Ligand-Target Pair
Affinity DataIC50: <0.320nMAssay Description:Inhibition of BRAFMore data for this Ligand-Target Pair
Affinity DataIC50: <0.320nMAssay Description:Inhibition of BRAFMore data for this Ligand-Target Pair
Affinity DataIC50: <0.320nMAssay Description:Inhibition of BRAFMore data for this Ligand-Target Pair
Affinity DataIC50: <0.320nMAssay Description:Inhibition of BRAFMore data for this Ligand-Target Pair
TargetIsoleucine--tRNA ligase(Staphylococcus aureus)
Smithkline Beecham Pharmaceuticals
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 4.45nMAssay Description:Inhibitory activity against isoleucyl-tRNA synthetase (IRS) of Staphylococcus aureusMore data for this Ligand-Target Pair
TargetIsoleucine--tRNA ligase(Staphylococcus aureus)
Smithkline Beecham Pharmaceuticals
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.67nMAssay Description:Inhibitory activity against isoleucyl-tRNA synthetase (IRS) of Staphylococcus aureus NCTC 3571More data for this Ligand-Target Pair
TargetIsoleucine--tRNA ligase(Staphylococcus aureus)
Smithkline Beecham Pharmaceuticals
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.87nMAssay Description:Inhibitory activity against isoleucyl-tRNA synthetase (IRS) of Staphylococcus aureusMore data for this Ligand-Target Pair
TargetIsoleucine--tRNA ligase(Staphylococcus aureus)
Smithkline Beecham Pharmaceuticals
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 7.98nMAssay Description:Inhibitory activity against isoleucyl-tRNA synthetase (IRS) of Staphylococcus aureusMore data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase(Homo sapiens (Human))
Pfizer
Curated by ChEMBL
Pfizer
Curated by ChEMBL
Affinity DataIC50: 44nMpH: 7.4 T: 2°CAssay Description:AKT1 was assayed using constitutively active Myr-AKT1 in low-binding 96-well plates. The kinase reactions were initiated by the addition of assay mix...More data for this Ligand-Target Pair
Affinity DataIC50: 57nMpH: 7.4 T: 2°CAssay Description:AKT1 was assayed using constitutively active Myr-AKT1 in low-binding 96-well plates. The kinase reactions were initiated by the addition of assay mix...More data for this Ligand-Target Pair
Affinity DataIC50: 72nMpH: 7.4 T: 2°CAssay Description:AKT1 was assayed using constitutively active Myr-AKT1 in low-binding 96-well plates. The kinase reactions were initiated by the addition of assay mix...More data for this Ligand-Target Pair
Affinity DataIC50: 80nMpH: 7.4 T: 2°CAssay Description:AKT1 was assayed using constitutively active Myr-AKT1 in low-binding 96-well plates. The kinase reactions were initiated by the addition of assay mix...More data for this Ligand-Target Pair
Affinity DataIC50: 99nMpH: 7.4 T: 2°CAssay Description:AKT1 was assayed using constitutively active Myr-AKT1 in low-binding 96-well plates. The kinase reactions were initiated by the addition of assay mix...More data for this Ligand-Target Pair
Affinity DataIC50: 122nMpH: 7.4 T: 2°CAssay Description:AKT1 was assayed using constitutively active Myr-AKT1 in low-binding 96-well plates. The kinase reactions were initiated by the addition of assay mix...More data for this Ligand-Target Pair
Affinity DataIC50: 149nMpH: 7.4 T: 2°CAssay Description:AKT1 was assayed using constitutively active Myr-AKT1 in low-binding 96-well plates. The kinase reactions were initiated by the addition of assay mix...More data for this Ligand-Target Pair
Affinity DataIC50: 150nMpH: 7.4 T: 2°CAssay Description:AKT1 was assayed using constitutively active Myr-AKT1 in low-binding 96-well plates. The kinase reactions were initiated by the addition of assay mix...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Homo sapiens (Human))
Pfizer
Curated by ChEMBL
Pfizer
Curated by ChEMBL
Affinity DataIC50: 163nMpH: 7.4 T: 2°CAssay Description:AKT1 was assayed using constitutively active Myr-AKT1 in low-binding 96-well plates. The kinase reactions were initiated by the addition of assay mix...More data for this Ligand-Target Pair